Review of Oximes in the Antidotal Treatment of Poisoning by Organophosphorus Nerve Agents

REFERENCES

• Petroianu G., Hardt F., Toomes M., Bergler W., Rüfer R. High-Dose Intravenous Paraoxon Exposure Does Not Cause Organophosphate-Induced Delayed Neuropathy (OPIDN) in Mini Pigs. J. Appl. Toxicol. 2001; 21: 263–268
   PubMed Web of Science ®Google Scholar
• Rakonczay Z., Papp H. Effects of Chronic Metrifonate Treatment on Cholinergic Enzymes and the Blood–Brain Barrier. Neurochem. Int. 2001; 39: 19–24
   PubMed Web of Science ®Google Scholar
• Lotti M. Organophosphorus Compounds. Experimental and Clinical Neurotoxicology, P.S. Spencer, H.H. Schaumburg. 2nd Ed., Oxford University Press, New York 2000; 898–925
   Google Scholar
• Marrs T.C. Organophosphate Poisoning. Pharmacol. Ther. 1993; 58: 51–66
   PubMed Web of Science ®Google Scholar
• Ohtomi S., Takase S., Kumagai F. Sarin Poisoning in Japan. A Clinical Experience in Japan Self Defense Force (JSDF) Central Hospital. Int. Rev. Arm. Ser. 1996; 69: 97–102
   Google Scholar
• Dawson R.M. Review of Oximes Available for the Treatment of Nerve Agent Poisoning. J. Appl. Toxicol. 1994; 14: 317–331
   PubMed Web of Science ®Google Scholar
• Taylor P. Anticholinesterase Agents. The Pharmacological Basis of Therapeutics, J.G. Hardman, L.E. Limbird. 9th Ed., McGraw Hill, New York 1996; 161–176
   Google Scholar
• Shih T.-M. Comparison of Several Oximes on Reactivation of Soman-Inhibited Blood, Brain and Tissue Cholinesterase Activity in Rats. Arch. Toxicol. 1993; 67: 637–646
   PubMed Web of Science ®Google Scholar
• Rousseaux C.G., Dua A.K. Pharmacology of HI-6, an H-series Oxime. Can. J. Physiol. Pharmacol. 1989; 67: 1183–1189
   PubMed Web of Science ®Google Scholar
• Eyer P., Hagedorn I., Klimmek R., Lippstreu P., Löffler M., Oldiges H., Spöhrer U., Steidl I., Szinicz L., Worek F. Hlö-7 Dimethanesulfonate, a Potent Bispyridinium-Dioxime Against Anticholinesterases. Arch. Toxicol. 1992; 66: 603–621
   PubMed Web of Science ®Google Scholar
• Eyer P., Hell W., Kawan A., Klehr H. Studies on the Decomposition of the Oxime HI-6 in Aqueous Solution. Arch. Toxicol. 1986; 59: 266–271
   PubMed Web of Science ®Google Scholar
• Eyer P., Ladstetter B., Schäfer W., Sonnenbichler J. Studies on the Stability and Decomposition of the Hagedorn-Oxime Hlö-7 in Aqueous Solution. Arch. Toxicol. 1989; 63: 59–67
   PubMed Web of Science ®Google Scholar
• Sundwall A. Minimum Concentrations of N-Methylpyridinium-2-aldoxime Methanesulphonate (P2S) Which Reverse Neuromuscular Block. Biochem. Pharmacol. 1961; 8: 413–417
   PubMed Web of Science ®Google Scholar
• Kusic R., Jovanovic D., Randjelovic S., Joksovic D., Todorovic V., Boskovic B., Jokanovic M., Vojvodic V. HI-6 in Man: Efficacy of the Oxime in Poisoning by Organophosphorus Insecticides. Hum. Exp. Toxicol. 1991; 10: 113–118
   PubMed Web of Science ®Google Scholar
• Sidell F.R., Groff W.A. Intramuscular and Intravenous Administration of Small Doses of 2-Pyridinium Aldoxime Methochloride to Man. J. Pharm. Sci. 1971; 60: 1224–1228
   PubMed Web of Science ®Google Scholar
• Kusic R., Boskovic B., Vojvodic V., Jovanovic D. HI-6 in Man: Blood Levels, Urinary Excretion, and Tolerance After Intramuscular Administration of the Oxime to Healthy Volunteers. Fundam. Appl. Toxicol. 1985; 5: S89–S97
   PubMedGoogle Scholar
• Sidell F.R., Groff W.A. Toxogonin: Blood Levels and Side Effects After Intramuscular Administration in Man. J. Pharm. Sci. 1970; 59: 793–797
   PubMed Web of Science ®Google Scholar
• Shiloff J.D., Clement J.G. Comparison of Serum Concentrations of the Acetylcholinesterase Oxime Reactivators HI-6, Obidoxime, and PAM to Efficacy Against Sarin (Isopropyl Methylphosphonofluoridate) Poisoning in Rats. Toxicol. Appl. Pharmacol. 1987; 89: 278–280
   PubMed Web of Science ®Google Scholar
• Clement J.G., Hansen A.S., Boulet C.A. Efficacy of HLö-7 and Pyrimidoxime as Antidotes of Nerve Agent Poisoning in Mice. Arch. Toxicol. 1992; 66: 216–219
   PubMed Web of Science ®Google Scholar
• Kassa J., Cabal J. A Comparison of the Efficacy of a New Asymmetric Bispyridinium Oxime BI-6 with Currently Available Oximes and H Oximes Against Soman by In Vitro and In Vivo Methods. Toxicology 1999; 132: 111–118
   PubMed Web of Science ®Google Scholar
• Faff J., Bax W. Increased Sensitivity to Obidoxime Induced by Fluostigmine in the Rat. Toxicol. Appl. Pharmacol. 1978; 46: 429–433
   PubMed Web of Science ®Google Scholar
• Bieger D., Wassermann O. Ionization Constants of Cholinesterase-Reactivating bis-Pyridinium Aldoximes. J. Pharm. Pharmacol. 1967; 19: 844–847
   PubMed Web of Science ®Google Scholar
• Kassa J., Cabal J. A Comparison of the Efficacy of a New Asymmetric Bispyridinium Oxime BI-6 with Presently Used Oximes and H Oximes Against Sarin by In Vitro and In Vivo Methods. Hum. Exp. Toxicol. 1999; 18: 560–565
   PubMed Web of Science ®Google Scholar
• Kassa J., Cabal J. A Comparison of the Efficacy of Acetylcholinesterase Reactivators Against Cyclohexyl Methylphosphonofluoridate (GF Agent) by In Vitro and In Vivo Methods. Pharmacol. Toxicol. 1999; 84: 41–45
   PubMedGoogle Scholar
• Clement J.G. Central Activity of Acetylcholinesterase Oxime Reactivators. Toxicol. Appl. Pharmacol. 1992; 112: 104–109
   PubMed Web of Science ®Google Scholar
• Kassa J. A Comparison of the Efficacy of New Asymmetric Bispyridinium Oxime BI-6 with Other Oximes (Obidoxime, HI-6) Against Soman in Rats. Hum. Exp. Toxicol. 1998; 17: 331–335
   PubMed Web of Science ®Google Scholar
• Kassa J., Bajgar J. Comparison of the Efficacy of HI-6 and Obidoxime Against Cyclohexyl Methylphosphonofluoridate (GF) in Rats. Hum. Exp. Toxicol. 1995; 14: 923–928
   PubMed Web of Science ®Google Scholar
• Koplovitz I., Gresham V.C., Dochterman L.W., Kaminskis A., Stewart J.R. Evaluation of the Toxicity, Pathology and Treatment of Cyclohexyl Methylphosphono-Fluoridate (CMPF) Poisoning in the Rhesus Monkey. Arch. Toxicol. 1992; 66: 622–628
   PubMed Web of Science ®Google Scholar
• Kassa J., Cabal J., Bajgar J., Szinicz L. The Choice: HI-6, Pralidoxime or Obidoxime Against Nerve Agents?. ASA Newslett. 1997; 97-4: 16–18
   Google Scholar
• Bajgar J. Present Views on Toxidynamics of Soman Poisoning. Acta Med. 1996; 39: 101–105
   Google Scholar
• Koplovitz I., Harris L.W., Anderson D.R., Lennox W.J., Stewart J.R. Reduction by Pyridostigmine Pretreatment of the Efficacy of Atropine and 2-PAM Treatment of Sarin and VX Poisoning in Rodents. Fundam. Appl. Toxicol. 1992; 18: 102–106
   PubMedGoogle Scholar
• Schoene K., Oldiges H. The Efficacy of Pyridinium Salts Against Tabun- and Sarin-Poisoning In Vivo and In Vitro. Arch. Int. Pharmacodyn. 1973; 204: 110–123
   PubMedGoogle Scholar
• Cetkovic S., Cerkovic M., Jandric D., Cosic M., Boskovic B. Effect of PAM-2 Cl, HI-6 and HGG-12 in Poisoning by Tabun and Its Thiocholine-like Analog in the Rat. Fundam. Appl. Toxicol. 1984; 4: S116–S123
   Google Scholar
• Hildebrandt H.J. Combined Antidote Therapy in Animals Poisoned with Tabun, Sarin and Soman. Naunyn-Schmiedebergs Arch. Pharmacol. Exp. Pathol. 1969; 263: 222–223
   Google Scholar
• Wang P.-H., Ma C., Liu R.-F., Shih J.-H. Design, Synthesis and Testing of New Oximes as Potential Antidotes Against Organophosphate Poisoning. J. Taiwan Pharm. Assoc. 1985; 37: 44–51
   Google Scholar
• Fleisher J.H., Harris L.W., Miller G.R., Thomas N.C., Cliff W.J. Antagonism of Sarin Poisoning in Rats and Guinea Pigs by Atropine, Oximes, and Mecamylamine. Toxicol. Appl. Pharmacol. 1970; 16: 40–47
   PubMedGoogle Scholar
• Urbanski R. Evaluation of the Therapeutic Effectiveness of Optimal Doses of Atropine Sulphate, Obidoxime and Diazepam in Acute Poisoning with Soman, Sarin and VX. Lek. Wojsk. 1988; 64: 486–490
   Google Scholar
• Maxwell D.M., Brecht K.M. The Role of Carboxylesterase in Species Variation of Oxime Protection Against Soman. Neurosci. Biobehav. Rev. 1991; 15: 135–139
   PubMed Web of Science ®Google Scholar
• Patocka J., Jakl A., Bajgar J., Fusek J. Efficacy of Various Pretreatment and Therapy Regiments Against Soman Lethality in Mice. Sb. Ved. Pr. Lék. Fak. Karlovy Univ. Hradci Kralové 1991; 34: 243–247
   PubMedGoogle Scholar
• Shih T.-M., Whalley C.E., Valdes J.J. A Comparison of Cholinergic Effects of HI-6 and Pralidoxime-2-chloride (2-PAM) in Soman Poisoning. Toxicol. Lett. 1991; 55: 131–147
   PubMed Web of Science ®Google Scholar
• Dube S.N., Kumar D., Sikder A.K., Jaiswal D.K., Das Gupta S. Therapeutic Efficacy of bis-Pyridinium Oximes Against Diisopropylfluorophosphate (DFP) and Soman Intoxication in Rodents. Pharmazie 1992; 47: 68–69
   PubMed Web of Science ®Google Scholar
• Lennox W.J., Harris L.W., Talbot B.G., Anderson D.R. Relationship Between Reversible Acetylcholinesterase Inhibition Against Soman Lethality. Life Sci. 1985; 37: 793–798
   PubMed Web of Science ®Google Scholar
• Maksimovic M., Boskovic B., Radovic L., Vadic V., Deljac V., Binenfeld Z. Antidotal Effects of bis-Pyridinium-2-monoxime Carbonyl Derivatives in Intoxications with Highly Toxic Organophosphorus Compounds. Acta Pharm. Jugosl. 1980; 30: 151–160
   Google Scholar
• Anderson D.R., Harris L.W., Woodard C.L., Lennox W.J. The Effect of Pyridostigmine Pretreatment on Oxime Efficacy Against Intoxication by Soman or VX in Rats. Drug Chem. Toxicol. 1992; 15: 285–294
   PubMed Web of Science ®Google Scholar
• Das Gupta S., Bhattacharya R., Purnanand P., Pant B.P. Protection Studies on Anticholinesterase Agents in Rats. Pharmazie 1990; 45: 801–802
   PubMed Web of Science ®Google Scholar
• Wilhelm K., Fajdetic A., Deljac V., Binenfeld Z. Protective Effect of Dexetimine and HI-6 in Poisoning with Highly Toxic Organophosphorus Compounds. Arh. Hig. Rada Toksikol. 1979; 30: 147–151
   PubMedGoogle Scholar
• Clement J.G., Shiloff J.D., Gennings C. Efficacy of the Combination of Acetylcholinesterase Reactivators, HI-6 and Obidoxime, Against Tabun and Soman Poisoning in Mice. J. Chromatogr. 1987; 389: 87–94
   PubMedGoogle Scholar
• Jokanovic M., Maksimovic M., Kilibarda V., Jovanovic D., Savic D. Oxime-Induced Reactivation of Acetylcholinesterase Inhibited by Phosphoramidates. Toxicol. Lett. 1996; 85: 35–39
   PubMed Web of Science ®Google Scholar
• Koplovitz I., Menton R., Matthews C., Shutz M., Nalls C., Kelly S. Dose-Response Effects of Atropine and HI-6 Treatment of Organophosphorus Poisoning in Guinea Pigs. Drug Chem. Toxicol. 1995; 18: 119–136
   PubMed Web of Science ®Google Scholar
• Puu G., Artursson E., Bucht G. Reactivation of Nerve Agent Inhibited Acetylcholinesterase by HI-6 and Obidoxime. Biochem. Pharmacol. 1986; 35: 1505–1510
   PubMed Web of Science ®Google Scholar
• Eto M. Organophosphorus Pesticides. Organic and Biological Chemistry. CRC Press Inc., Cleveland 1976; 142–143
   Google Scholar
• Cabal C., Bajgar J. Tabun—Return Following 50 Years. Chem. Listy 1999; 93: 27–31
   Web of Science ®Google Scholar
• Fleisher J.H., Harris L.W. Dealkylation as a Mechanism for Aging of Cholinesterase After Poisoning with Pinacolyl Methylphosphonofluoridate. Biochem. Phamacol. 1965; 14: 641–649
   PubMed Web of Science ®Google Scholar
• Kadar T., Raveh L., Cohen G., Oz N., Baraness I., Balon A., Ashani Z., Shapira S. Distribution of 3H-Soman in Mice. Arch. Toxicol. 1985; 58: 45–49
   PubMed Web of Science ®Google Scholar
• Kassa J. Comparison of Efficacy of Two Oximes (HI-6 and Obidoxime) in Soman Poisoning in Rats. Toxicology 1995; 101: 167–174
   PubMed Web of Science ®Google Scholar
• Koplovitz I., Stewart J.R. A Comparison of the Efficacy of HI-6 and 2-PAM Against Soman, Tabun, Sarin and VX in the Rabbit. Toxicol. Lett. 1994; 70: 169–179
   Web of Science ®Google Scholar
• Leadbeater L., Inns R.H., Rylands J.M. Treatment of Poisoning by Soman. Fundam. Appl. Toxicol. 1985; 5: S225–S231
   PubMedGoogle Scholar
• Kassa J., Bajgar J. A Comparison of the Efficacy of Antidotes Against Acute Poisoning with Organophosphorus Insecticides in Mice. Prac. Lék. 1996; 48: 55–58
   Google Scholar
• Worek F., Kirchner T., Bächer M., Szinicz L. Reaction by Various Oximes of Human Erythrocyte Acetylcholinesterase Inhibited by Different Organophosphorus Compounds. Arch. Toxicol. 1996; 70: 486–503
   Google Scholar